テイサックス病治療の世界市場レポート 2025年

テイサックス病治療市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）7.3％で32億5,000万米ドルに成長します。予測期間中の成長は、ライソゾーム貯蔵障害の有病率の上昇、啓発活動の増加、遺伝子検査サービスの拡大、対症療法に対する需要の高まり、遺伝性疾患の有病率の上昇などによると考えられます。主な動向としては、遺伝子治療の進歩、費用対効果の高い次世代シーケンシング、自動クローニングプラットフォーム、ドラッグデリバリーシステムの革新、AIと機械学習の統合、遠隔医療ソリューションの採用などが挙げられます。

遺伝性疾患の有病率の増加は、テイサックス病治療市場の進歩を促進すると予想されます。遺伝性疾患は、遺伝性または自然変異による個人のDNAの異常から生じる。これらの疾患の増加は、診断法の改善、意識の高まり、環境要因、子育ての遅れやライフスタイルの変化に伴う変異率の上昇に起因しています。遺伝性疾患の増加は、遺伝子治療、酵素補充、早期診断の研究に拍車をかけ、テイサックス病治療の進歩の必要性を強調しています。例えば、2022年2月、英国の政府機関であるジェノミクス・イングランドは、7,000を超える希少疾病が認められ、英国では約17人に1人（350万人）が罹患していると報告しました。その結果、遺伝性疾患の有病率の上昇は、テイサックス病治療市場を前進させると予想されます。

テイサックス病治療市場の主要企業は、遺伝子治療、酵素補充、低分子医薬品など、患者の予後を改善する可能性のある治療法を探るため、臨床試験を含む革新的な治療に注力しています。臨床試験とは、ヒトにおける治療、薬剤、処置の安全性、有効性、潜在的副作用を評価する調査研究です。例えば、2024年7月、米国のバイオ医薬品会社であるイントラバイオ社は、GM2ガングリオシドーシス（テイ・サックス病、サンドホフ病）をターゲットとしたIB1001の臨床試験（IB1001-202）を実施するための治験薬（IND）申請について、米国食品医薬品局（FDA）の承認を得たと発表しました。この臨床試験は、米国、英国、ドイツ、スペインで実施され、現在治療法が承認されていないこれらの致死的な神経変性疾患に対処します。イントラバイオ社の会長は、これらの衰弱性疾患に対する効果的な治療法の開発が急務であることを強調しました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界テイサックス病治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のテイサックス病治療市場：成長率分析
• 世界のテイサックス病治療市場の実績：規模と成長, 2019-2024
• 世界のテイサックス病治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界テイサックス病治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のテイサックス病治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• 呼吸ケア
• 理学療法
• 世界のテイサックス病治療市場投与方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射剤
• オーラル
• その他の投与方法
• 世界のテイサックス病治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界のテイサックス病治療市場、医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗てんかん薬
• ミグルスタット
• 対症療法薬
• 世界のテイサックス病治療市場呼吸ケアのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機械的人工呼吸器
• 気道クリアランス療法
• 酸素療法
• 世界のテイサックス病治療市場理学療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 運動機能訓練
• ハイドロセラピー
• 移動補助装置

第7章 地域別・国別分析

• 世界のテイサックス病治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のテイサックス病治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• テイサックス病治療市場：競合情勢
• テイサックス病治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Biogen Inc.
• Vertex Pharmaceuticals Incorporated
• BioMarin Pharmaceutical Inc.
• Sarepta Therapeutics Inc.
• Ultragenyx Pharmaceutical Inc.
• Amicus Therapeutics Inc.
• Spark Therapeutics Inc.
• Rocket Pharmaceuticals Inc.
• RegenxBio Inc.
• Forge Biologics Inc.
• Passage Bio Inc.
• Protalix BioTherapeutics Inc.
• Orchard Therapeutics plc
• Affinia Therapeutics Inc.
• IntraBio Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• テイサックス病治療市場2029：新たな機会を提供する国
• テイサックス病治療市場2029：新たな機会を提供するセグメント
• テイサックス病治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Tay-Sachs disease treatment encompasses therapeutic approaches aimed at managing or potentially curing this rare genetic disorder caused by a deficiency of the enzyme hexosaminidase A (Hex-A). Current treatment efforts include experimental gene therapy, substrate reduction therapy, and supportive care to alleviate symptoms and improve the quality of life for affected individuals.

The primary treatment options for Tay-Sachs disease include medication, respiratory care, and physical therapy. Medication involves prescribed drugs designed to relieve symptoms, slow disease progression, and enhance patient comfort by addressing pain, seizures, muscle stiffness, and related complications. These treatments are administered through various modes, including injectable, oral, and other methods, and are utilized in hospitals, homecare settings, and specialty clinics.

The tay-sachs disease treatment market research report is one of a series of new reports from The Business Research Company that provides tay-sachs disease treatment market statistics, including the tay-sachs disease treatment industry's global market size, regional shares, competitors with a tay-sachs disease treatment market share, detailed tay-sachs disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tay-sachs disease treatment industry. This tay-sachs disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tay-sachs disease treatment market size has grown strongly in recent years. It will grow from $2.28 billion in 2024 to $2.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be credited to the increasing prevalence of Tay-Sachs disease, a greater focus on rare diseases, the rise in genetic screening initiatives, the growing demand for quality healthcare, and the overall increase in chronic condition cases.

The tay-sachs disease treatment market size is expected to see strong growth in the next few years. It will grow to $3.25 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth during the forecast period can be credited to the rising prevalence of lysosomal storage disorders, increasing awareness initiatives, the expansion of genetic testing services, growing demand for symptomatic treatments, and the rising prevalence of genetic diseases. Key trends include advancements in gene therapy, cost-effective next-generation sequencing, automated cloning platforms, innovations in drug delivery systems, the integration of AI and machine learning, and the adoption of telemedicine solutions.

The increasing prevalence of genetic diseases is expected to drive advancements in the Tay-Sachs disease treatment market. Genetic diseases result from abnormalities in an individual's DNA, either inherited or caused by spontaneous mutations. The rise in these conditions is attributed to improved diagnostics, heightened awareness, environmental factors, and higher mutation rates associated with delayed parenthood and lifestyle changes. The growing occurrence of genetic diseases underscores the need for advancements in Tay-Sachs disease treatment, fueling research in gene therapy, enzyme replacement, and early diagnostics. For example, in February 2022, Genomics England, a UK-based government organization, reported that over 7,000 recognized rare diseases affect approximately 1 in 17 people (3.5 million) in the UK. Consequently, the rising prevalence of genetic diseases is expected to drive the Tay-Sachs disease treatment market forward.

Leading companies in the Tay-Sachs disease treatment market are focusing on innovative therapies, including clinical trials, to explore potential treatments such as gene therapy, enzyme replacement, and small-molecule drugs for improved patient outcomes. Clinical trials are research studies that assess the safety, effectiveness, and potential side effects of medical treatments, drugs, or procedures in humans. For instance, in July 2024, IntraBio Inc., a US-based biopharmaceutical company, announced that it had received US Food and Drug Administration (FDA) approval for its Investigational New Drug (IND) Application to conduct a clinical trial (IB1001-202) for IB1001, targeting GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease). The trial is being conducted in the U.S., UK, Germany, and Spain to address these fatal neurodegenerative disorders, which currently have no approved treatments. IntraBio's chairman emphasized the urgent need to develop effective therapies for these debilitating conditions.

In June 2023, New Hope Research Foundation Inc., a US-based non-profit research organization, partnered with Forge Biologics Inc. to advance its innovative gene therapy, NHR01, into Phase I/II clinical trials for patients with Tay-Sachs disease and GM2 gangliosidosis. Forge Biologics, a US-based biotechnology company, specializes in gene therapy contract manufacturing and clinical-stage therapeutics.

Major players in the tay-sachs disease treatment market are Pfizer Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Pharmaceutical Inc., Amicus Therapeutics Inc., Spark Therapeutics Inc., Rocket Pharmaceuticals Inc., RegenxBio Inc., Forge Biologics Inc., Passage Bio Inc., Protalix BioTherapeutics Inc., Orchard Therapeutics plc, Affinia Therapeutics Inc., IntraBio Inc., and Taysha Gene Therapies Inc.

North America was the largest region in the tay-sachs disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tay-sachs disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tay-sachs disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tay-sachs disease treatment market consists of revenues earned by providing services such as respiratory care, physical therapy, genetic counseling, and home care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The tay-sachs disease treatment market includes sales of anticonvulsants, gene therapy products, supportive care products, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tay-Sachs Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tay-sachs disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tay-sachs disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tay-sachs disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Medication; Respiratory Care; Physical Therapy
• 2) By Mode Of Administration: Injectable; Oral; Other Mode Of Administration
• 3) By End-Users: Hospitals; Homecare; Specialty Clinics
• Subsegments:
• 1) By Medication: Antiepileptic Drugs; Miglustat; Supportive Symptomatic Medications
• 2) By Respiratory Care: Mechanical Ventilation; Airway Clearance Therapy; Oxygen Therapy
• 3) By Physical Therapy: Motor Function Exercises; Hydrotherapy; Assistive Mobility Devices
• Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Novartis AG; Takeda Pharmaceutical Company Limited; Regeneron Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tay-Sachs Disease Treatment Market Characteristics

3. Tay-Sachs Disease Treatment Market Trends And Strategies

4. Tay-Sachs Disease Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tay-Sachs Disease Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tay-Sachs Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tay-Sachs Disease Treatment Market Growth Rate Analysis
• 5.4. Global Tay-Sachs Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tay-Sachs Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tay-Sachs Disease Treatment Total Addressable Market (TAM)

6. Tay-Sachs Disease Treatment Market Segmentation

• 6.1. Global Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Respiratory Care
• Physical Therapy
• 6.2. Global Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Oral
• Other Mode Of Administration
• 6.3. Global Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End User
• 6.4. Global Tay-Sachs Disease Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiepileptic Drugs
• Miglustat
• Supportive Symptomatic Medications
• 6.5. Global Tay-Sachs Disease Treatment Market, Sub-Segmentation Of Respiratory Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mechanical Ventilation
• Airway Clearance Therapy
• Oxygen Therapy
• 6.6. Global Tay-Sachs Disease Treatment Market, Sub-Segmentation Of Physical Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Motor Function Exercises
• Hydrotherapy
• Assistive Mobility Devices

7. Tay-Sachs Disease Treatment Market Regional And Country Analysis

• 7.1. Global Tay-Sachs Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tay-Sachs Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tay-Sachs Disease Treatment Market

• 8.1. Asia-Pacific Tay-Sachs Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tay-Sachs Disease Treatment Market

• 9.1. China Tay-Sachs Disease Treatment Market Overview
• 9.2. China Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tay-Sachs Disease Treatment Market

• 10.1. India Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tay-Sachs Disease Treatment Market

• 11.1. Japan Tay-Sachs Disease Treatment Market Overview
• 11.2. Japan Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tay-Sachs Disease Treatment Market

• 12.1. Australia Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tay-Sachs Disease Treatment Market

• 13.1. Indonesia Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tay-Sachs Disease Treatment Market

• 14.1. South Korea Tay-Sachs Disease Treatment Market Overview
• 14.2. South Korea Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tay-Sachs Disease Treatment Market

• 15.1. Western Europe Tay-Sachs Disease Treatment Market Overview
• 15.2. Western Europe Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tay-Sachs Disease Treatment Market

• 16.1. UK Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tay-Sachs Disease Treatment Market

• 17.1. Germany Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tay-Sachs Disease Treatment Market

• 18.1. France Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tay-Sachs Disease Treatment Market

• 19.1. Italy Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tay-Sachs Disease Treatment Market

• 20.1. Spain Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tay-Sachs Disease Treatment Market

• 21.1. Eastern Europe Tay-Sachs Disease Treatment Market Overview
• 21.2. Eastern Europe Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tay-Sachs Disease Treatment Market

• 22.1. Russia Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tay-Sachs Disease Treatment Market

• 23.1. North America Tay-Sachs Disease Treatment Market Overview
• 23.2. North America Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tay-Sachs Disease Treatment Market

• 24.1. USA Tay-Sachs Disease Treatment Market Overview
• 24.2. USA Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tay-Sachs Disease Treatment Market

• 25.1. Canada Tay-Sachs Disease Treatment Market Overview
• 25.2. Canada Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tay-Sachs Disease Treatment Market

• 26.1. South America Tay-Sachs Disease Treatment Market Overview
• 26.2. South America Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tay-Sachs Disease Treatment Market

• 27.1. Brazil Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tay-Sachs Disease Treatment Market

• 28.1. Middle East Tay-Sachs Disease Treatment Market Overview
• 28.2. Middle East Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tay-Sachs Disease Treatment Market

• 29.1. Africa Tay-Sachs Disease Treatment Market Overview
• 29.2. Africa Tay-Sachs Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tay-Sachs Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tay-Sachs Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tay-Sachs Disease Treatment Market Competitive Landscape And Company Profiles

• 30.1. Tay-Sachs Disease Treatment Market Competitive Landscape
• 30.2. Tay-Sachs Disease Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tay-Sachs Disease Treatment Market Other Major And Innovative Companies

• 31.1. Biogen Inc.
• 31.2. Vertex Pharmaceuticals Incorporated
• 31.3. BioMarin Pharmaceutical Inc.
• 31.4. Sarepta Therapeutics Inc.
• 31.5. Ultragenyx Pharmaceutical Inc.
• 31.6. Amicus Therapeutics Inc.
• 31.7. Spark Therapeutics Inc.
• 31.8. Rocket Pharmaceuticals Inc.
• 31.9. RegenxBio Inc.
• 31.10. Forge Biologics Inc.
• 31.11. Passage Bio Inc.
• 31.12. Protalix BioTherapeutics Inc.
• 31.13. Orchard Therapeutics plc
• 31.14. Affinia Therapeutics Inc.
• 31.15. IntraBio Inc.

32. Global Tay-Sachs Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tay-Sachs Disease Treatment Market

34. Recent Developments In The Tay-Sachs Disease Treatment Market

35. Tay-Sachs Disease Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Tay-Sachs Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tay-Sachs Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tay-Sachs Disease Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer